EasyFinance Live
Sign in

How Much Tax Does a 66-Year-Old Owe Selling $600,000 in Micron and Oracle Gains?

Yahoo! Finance ·

Key points

  • The couple holds $600,000 of long‑term gains in Micron Technology and Oracle in a taxable brokerage account, filing jointly.
  • Option 1 (sell all in 2026): taxable income hits $667,800 after the standard deduction, yielding $105,140 in federal tax plus $17,100 NIIT, for a total of about $122,240; the NIIT drives the bulk of the extra cost because gains exceed thresholds.
  • Option 2 (spread across 2026–2028): selling $200,000 per year keeps taxable income around $267,800 annually, producing about $27,235 per year in tax (including a $1,900 NIIT) and $81,705 over three years; this is roughly $23,435 less federal tax than the lump sale.
  • Medicare IRMAA surcharges are calculated two years later; a lump sale drives higher premiums than spreading, with total extra premiums around $12,710 in the lump case versus about $17,309 over three years for the spread.
  • Even after higher Medicare costs, the spread-out plan remains ahead by about $18,800 under the given assumptions, though it requires holding two-thirds of the positions longer and risking price declines.
  • Price risk is highlighted: Micron fell about 31% in a month, while Oracle dropped about 51% over a year, illustrating how unsold gains can shrink quickly and affect wealth.
  • Other levers include potential state taxes, additional capital losses, and the possibility of net unrealized appreciation (NUA) considerations; year-end sales and future threshold updates will influence the second and third-year brackets.

Summary

A 66-year-old married couple holding $600,000 in long-term gains from Micron and Oracle faces a choice between selling all gains in 2026 or spreading the sales over multiple years. With a lump sale, federal tax plus NIIT reaches about $105,000, while spreading over three years reduces three-year federal tax to about $82,000 but raises Medicare premiums by roughly $4,600 per year, netting a small overall gain. The spread option avoids a large 2026 tax hit but exposes the portfolio to price swings in Micron and Oracle, which have posted sharp declines at times. Overall, spreading yields a modest net advantage but still entails greater exposure to market risk and higher future Medicare costs. Next steps hinge on year-by-year thresholds, market moves, and evolving IRS/CMS rules.

This summary was written with AI. The full story has every detail.

Related